Last quarter (Q3 2025), CAMP4 Therapeutics Corporation's total revenue was $795.00K, an increase of Infinity% from the same quarter last year. In Q3, CAMP4 Therapeutics Corporation's net income was $-15.10M. See CAMP4 Therapeutics Corporation’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 652.00K	$ 350.00K	$ 0.00	$ 295.84M	$ 308.59M
Gross Profit	$ 652.00K	$ 350.00K	$ 0.00	$ 121.89M	$ 122.41M
Operating Expenses	$ 53.74M	$ 52.23M	$ 45.00M	$ 134.76M	$ 125.87M
Depreciation and Amortization	$ 1.70M	$ 1.68M	$ 878.00K	$ 22.80M	$ 22.00M
EBITDA	$ -51.39M	$ -50.20M	$ -44.12M	$ 7.49M	$ 18.13M
Operating Income	$ -53.09M	$ -51.88M	$ -45.00M	$ -15.31M	$ -3.87M
Other Income/Expenses	$ 1.30M	$ 2.59M	$ 809.00K	$ -14.75M	$ -16.73M
Pretax Income	$ -51.79M	$ -49.29M	$ -44.19M	$ -30.06M	$ -20.60M
Net Income	$ -51.79M	$ -49.29M	$ -44.19M	$ -31.15M	$ -21.16M
Per Share Metrics
Basic EPS	$ -2.66	$ -4.07	$ -0.90	$ -0.88	$ -0.62
Diluted EPS	$ -2.66	$ -4.07	$ -0.90	$ -0.88	$ -0.62
Weighted Average Shares Outstanding	19.51M	12.12M	36.10M	35.25M	34.12M
Weighted Average Shares Outstanding (Diluted)	19.51M	12.12M	36.13M	35.25M	34.39M

Currency in USD

CAMP4 Therapeutics Corporation Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing